OBESITY EFFECTS ON NITRAZEPAM DISPOSITION

被引：19
作者：
ABERNETHY, DR
GREENBLATT, DJ
LOCNISKAR, A
OCHS, HR
HARMATZ, JS
SHADER, RI
机构：
[1] BAYLOR COLL MED,HYPERTENS CLIN PHARMACOL SECT,HOUSTON,TX 77030
[2] TUFTS UNIV,NEW ENGLAND MED CTR,DIV CLIN PHARMACOL,BOSTON,MA 02111
[3] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷 / 05期
关键词：
D O I：
10.1111/j.1365-2125.1986.tb02934.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：551 / 557
页数：7
相关论文
共 22 条
[1]   THE INFLUENCE OF OBESITY ON THE PHARMACOKINETICS OF ORAL ALPRAZOLAM AND TRIAZOLAM [J].
ABERNETHY, DR ;
GREENBLATT, DJ ;
DIVOLL, M ;
SMITH, RB ;
SHADER, RI .
CLINICAL PHARMACOKINETICS, 1984, 9 (02) :177-183
[2]  
ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[3]  
ARENDT RM, 1983, J PHARMACOL EXP THER, V227, P98
[4]   INTERINDIVIDUAL VARIATIONS IN DRUG DISPOSITION - CLINICAL IMPLICATIONS AND METHODS OF INVESTIGATION [J].
BREIMER, DD .
CLINICAL PHARMACOKINETICS, 1983, 8 (05) :371-377
[5]  
DAWSON GW, 1982, PHARMACOL THERAPEUT, V15, P207
[6]   CIMETIDINE IMPAIRS ELIMINATION OF CHLORDIAZEPOXIDE (LIBRIUM) IN MAN [J].
DESMOND, PV ;
PATWARDHAN, RV ;
SCHENKER, S ;
SPEEG, KV .
ANNALS OF INTERNAL MEDICINE, 1980, 93 (02) :266-268
[7]  
GREENBLATT DJ, 1983, NEW ENGL J MED, V309, P354
[8]  
GREENBLATT DJ, 1983, NEW ENGL J MED, V309, P410
[9]   AGE, SEX, AND NITRAZEPAM KINETICS - RELATION TO ANTIPYRINE DISPOSITION [J].
GREENBLATT, DJ ;
ABERNETHY, DR ;
LOCNISKAR, A ;
OCHS, HR ;
HARMATZ, JS ;
SHADER, RI .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :697-703
[10]  
HOLM V, 1982, Drug-Nutrient Interactions, V1, P307
123